<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="050522-2018"
            EDITION="2018024">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-052713-001</RECEPTION_ID>
      <DELETION_DATE>20180305</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>24</NO_OJ>
         <DATE_PUB>20180203</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 024-050522</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:050522-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="IE"/>
         <IA_URL_GENERAL>http://www.hse.ie</IA_URL_GENERAL>
         <IA_URL_ETENDERING>http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=124579&amp;B=ETENDERS_SIMPLE</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="IE">IRELAND</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="IE">IRELAND</n2016:CA_CE_NUTS>
         <VALUES>
            <VALUE TYPE="ESTIMATED_TOTAL" CURRENCY="EUR">1.00</VALUE>
         </VALUES>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180201</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180305 10:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="4">European Union</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>01B02</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Иpлaндия</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Irsko</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Irland</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Irland</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Ιρλανδία</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Ireland</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Irlanda</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Iirimaa</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Irlanti</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Irlande</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Éire</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Irska</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Írország</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Irlanda</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Airija</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Īrija</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>l-Irlanda</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Ierland</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Irlandia</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Irlanda</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Irlanda</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Írsko</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Irska</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Irland</TI_CY>
            <TI_TOWN>Naas</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Health Service Executive (HSE)</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <NOTICE_UUID>f8d08908-cf2f-48fb-8b04-50c71b03631b</NOTICE_UUID>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Health Service Executive (HSE)</OFFICIALNAME>
               <NATIONALID>N/A</NATIONALID>
               <ADDRESS>Head Office</ADDRESS>
               <TOWN>Naas</TOWN>
               <POSTAL_CODE>Millennium Park</POSTAL_CODE>
               <COUNTRY VALUE="IE"/>
               <CONTACT_POINT>Sabrina Byrne</CONTACT_POINT>
               <E_MAIL>sabrina.byrne@hse.ie</E_MAIL>
               <n2016:NUTS CODE="IE"/>
               <URL_GENERAL>http://www.hse.ie</URL_GENERAL>
               <URL_BUYER>https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461</URL_BUYER>
            </ADDRESS_CONTRACTING_BODY>
            <CENTRAL_PURCHASING/>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=124579&amp;B=ETENDERS_SIMPLE</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>http://irl.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=124579&amp;B=ETENDERS_SIMPLE</URL_PARTICIPATION>
            <ADDRESS_PARTICIPATION_IDEM/>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>National Multi Supplier Contract for DAA Medicines for the National Hepatitis C Treatment Programme</P>
            </TITLE>
            <REFERENCE_NUMBER>HSE 9966</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>The HSE wishes to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment for hepatitis C to patients across all genotypes in 2018.</P>
               <P>The National Hepatitis C Treatment Programme (NHCTP) aims to provide treatment to every person with hepatitis C over the coming years so that it is a rare disease in Ireland by 2026. There are approximately 30 000 people in Ireland living with hepatitis C. The NHCTP was established in 2015 in response to the Department of Health Report “A Public Health Plan for the Therapeutic Treatment of Hepatitis C”. The NHCTP has received an annual budget of EUR 30 000 000 for all programme activities since 2015 and the NHCTP is currently planning treatment for 2018 within budget.</P>
               <P>This tender process is to cover patients initiating Hepatitis C treatment up to and including 28.2.2019.</P>
            </SHORT_DESCR>
            <VAL_ESTIMATED_TOTAL CURRENCY="EUR">1.00</VAL_ESTIMATED_TOTAL>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33600000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="IE"/>
               <MAIN_SITE>
                  <P>Ireland.</P>
               </MAIN_SITE>
               <SHORT_DESCR>
                  <P>The HSE wishes to establish a national multi supplier contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment for hepatitis C to patients across all genotypes in 2018.</P>
                  <P>The National Hepatitis C Treatment Programme (NHCTP) aims to provide treatment to every person with hepatitis C over the coming years so that it is a rare disease in Ireland by 2026. There are approximately 30 000 people in Ireland living with hepatitis C. The NHCTP was established in 2015 in response to the Department of Health Report “A Public Health Plan for the Therapeutic Treatment of Hepatitis C”. The NHCTP has received an annual budget of EUR 30 000 000 for all programme activities since 2015 and the NHCTP is currently planning treatment for 2018 within budget.</P>
                  <P>This tender process is to cover patients initiating Hepatitis C treatment up to and including 28.2.019.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <VAL_OBJECT CURRENCY="EUR">1.00</VAL_OBJECT>
               <DURATION TYPE="MONTH">12</DURATION>
               <NO_RENEWAL/>
               <NO_ACCEPTED_VARIANTS/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <LEFTI>
            <SUITABILITY>
               <P>As per Tender Documentation.</P>
            </SUITABILITY>
            <ECONOMIC_CRITERIA_DOC/>
            <TECHNICAL_CRITERIA_DOC/>
         </LEFTI>
         <PROCEDURE>
            <PT_OPEN/>
            <NO_CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-03-05</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>10:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="EN"/>
            </LANGUAGES>
            <DURATION_TENDER_VALID TYPE="MONTH">6</DURATION_TENDER_VALID>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-03-05</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>10:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>The High Court</OFFICIALNAME>
               <ADDRESS>Four Courts</ADDRESS>
               <TOWN>Dublin</TOWN>
               <COUNTRY VALUE="IE"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-02-01</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
